{"id":48972,"date":"2022-09-29T15:01:57","date_gmt":"2022-09-29T13:01:57","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\/"},"modified":"2022-09-29T15:01:57","modified_gmt":"2022-09-29T13:01:57","slug":"dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\/","title":{"rendered":"Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time."},"content":{"rendered":"
\n

SAN DIEGO–(BUSINESS WIRE)–DexCom, Inc.<\/a> (NASDAQ:DXCM) today announced that it plans to release its third quarter 2022 financial results after market close on Thursday, October 27, 2022. Management will hold a conference call to review the company’s third quarter 2022 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com<\/a> and will be archived there for future reference.\n<\/p>\n

<\/a><\/p>\n

\nTo listen to the conference call, please dial (866) 374-5140 (US\/Canada) or (404) 400-0571 (International) and use the confirmation number “56107665#” approximately five minutes prior to the start time.\n<\/p>\n

\nAbout DexCom, Inc.<\/b>\n<\/p>\n

\nDexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nDexCom, Inc.:<\/b>
Sean Christensen
\n
Vice President \u2013 Finance and Investor Relations
\n
investor-relations@dexcom.com<\/a>
(858) 200-0200\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO–(BUSINESS WIRE)–DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2022 financial results after market close on Thursday, October 27, 2022. Management will hold a conference call to review the company’s third quarter 2022 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48972","6":"format-standard","7":"category-industry"},"yoast_head":"\nDexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time. - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time. - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO–(BUSINESS WIRE)–DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2022 financial results after market close on Thursday, October 27, 2022. Management will hold a conference call to review the company’s third quarter 2022 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-29T13:01:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220929005252\/en\/685171\/21\/Dexcom_Registered_no_bug.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time.\",\"datePublished\":\"2022-09-29T13:01:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\\\/\"},\"wordCount\":194,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220929005252\\\/en\\\/685171\\\/21\\\/Dexcom_Registered_no_bug.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\\\/\",\"name\":\"Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time. - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220929005252\\\/en\\\/685171\\\/21\\\/Dexcom_Registered_no_bug.jpg\",\"datePublished\":\"2022-09-29T13:01:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220929005252\\\/en\\\/685171\\\/21\\\/Dexcom_Registered_no_bug.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220929005252\\\/en\\\/685171\\\/21\\\/Dexcom_Registered_no_bug.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time. - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\/","og_locale":"en_US","og_type":"article","og_title":"Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time. - Pharma Trend","og_description":"SAN DIEGO–(BUSINESS WIRE)–DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2022 financial results after market close on Thursday, October 27, 2022. Management will hold a conference call to review the company’s third quarter 2022 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-29T13:01:57+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220929005252\/en\/685171\/21\/Dexcom_Registered_no_bug.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time.","datePublished":"2022-09-29T13:01:57+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\/"},"wordCount":194,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220929005252\/en\/685171\/21\/Dexcom_Registered_no_bug.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\/","url":"https:\/\/pharma-trend.com\/en\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\/","name":"Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time. - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220929005252\/en\/685171\/21\/Dexcom_Registered_no_bug.jpg","datePublished":"2022-09-29T13:01:57+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220929005252\/en\/685171\/21\/Dexcom_Registered_no_bug.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220929005252\/en\/685171\/21\/Dexcom_Registered_no_bug.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/dexcom-schedules-third-quarter-2022-earnings-release-and-conference-call-for-october-27-2022-at-430-p-m-eastern-time\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time."}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48972","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48972"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48972\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48972"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48972"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48972"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}